4.95500 USD
0.245
5.20%
Last update Dec 15, 3:59 PM EST
Post-market
Day range
4.72000
5.070000
Previous close
4.71000
Open
4.72000
Access this stock data via API
Subscribe
Arbutus Biopharma Corporation
4.96
0.25
5.20%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 6.2M 18.1M 39.0M 11.0M
Cost of revenue
Gross profit
Operating expense
Research & development 54.0M 73.7M 84.4M 65.5M
Selling general and admin 22.1M 22.5M 17.8M 17.1M
Other operating expenses
Operating income -70.0M -78.0M -63.2M -71.7M
Non operating interest income
Income 6.6M 5.7M 2.2M 127K
Expense 137K 459K 1.7M 2.9M
Other income expense -6.4M -44K -2.3M -1.9M
Pretax income -69.9M -72.8M -65.0M -76.2M
Tax provision 0 0 4.4M 0
Net income -69.9M -72.8M -69.5M -76.2M
Basic EPS -0.4 -0.4 -0.5 -0.8
Diluted EPS -0.4 -0.4 -0.5 -0.8
Basic average shares 185.6M 166.0M 150.9M 106.2M
Diluted average shares 185.6M 166.0M 150.9M 106.2M
EBITDA -62.0M -70.9M -59.6M -69.8M
Net income from continuing op. -69.9M -72.8M -69.5M -76.2M
Minority interests
Preferred stock dividends 0 12.1M
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 1 hour 36 minutes

18:24
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).